SWA
Sutton Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15
| Closed | -$1.16K | – | 1645 |
|
|
2022
Q1 | $1.16K | Hold |
15
| – | – | ﹤0.01% | 1304 |
|
|
2021
Q4 | $1.33K | Buy |
+15
| New | +$1.33K | ﹤0.01% | 1262 |
|
|
2020
Q2 | – | Sell |
-82
| Closed | -$6.93K | – | 1213 |
|
|
2020
Q1 | $6.93K | Hold |
82
| – | – | ﹤0.01% | 755 |
|
|
2019
Q4 | $6.93K | Sell |
82
-9
| -10% | -$761 | ﹤0.01% | 892 |
|
|
2019
Q3 | $6.13K | Sell |
91
-3
| -3% | -$202 | ﹤0.01% | 904 |
|
|
2019
Q2 | $8.05K | Sell |
94
-3
| -3% | -$257 | ﹤0.01% | 828 |
|
|
2019
Q1 | $8.62K | Buy |
97
+9
| +10% | +$800 | 0.01% | 820 |
|
|
2018
Q4 | $7.49K | Buy |
88
+82
| +1,367% | +$6.98K | ﹤0.01% | 804 |
|
|
2018
Q3 | $582 | Sell |
6
-251
| -98% | -$24.3K | ﹤0.01% | 1076 |
|
|
2018
Q2 | $24.2K | Hold |
257
| – | – | 0.02% | 526 |
|
|
2018
Q1 | $20.8K | Hold |
257
| – | – | 0.01% | 554 |
|
|
2017
Q4 | $22.9K | Hold |
257
| – | – | 0.02% | 510 |
|
|
2017
Q3 | $23.9K | Hold |
257
| – | – | 0.02% | 483 |
|
|
2017
Q2 | $23.3K | Hold |
257
| – | – | 0.02% | 468 |
|
|
2017
Q1 | $22.6K | Hold |
257
| – | – | 0.02% | 473 |
|
|
2016
Q4 | $21.3K | Buy |
257
+3
| +1% | +$249 | 0.02% | 471 |
|
|
2016
Q3 | $23.5K | Hold |
254
| – | – | 0.02% | 423 |
|
|
2016
Q2 | $19.8K | Hold |
254
| – | – | 0.02% | 451 |
|
|
2016
Q1 | $21K | Buy |
+254
| New | +$21K | 0.02% | 424 |
|